Here are four things to now:
1. CelgenTek Innovations is comprised of subsidiaries InnoVision and CelgenTek.
2. The company designs and manufactures the N-Force Fixation System and iN3 Cement.
3. The N-Force Fixation System is an augmented fixation system cleared in the United States and European Union. The iN3 is a pre-mix calcium phosphate cement available in the European Union.
4. The N-Force Fixation System allows healthcare professionals to directly administer Zimmer Biomet’s N-Force Blue-Bone Substitute Material and CelgenTek’s iN3 Cement directly through a fenestrated screw in a single integrated construct.
“The driving focus of Zimmer Biomet’s Trauma portfolio has always been to equip surgeons with exceptional tools that can unlock personalized outcomes for patients, whether they are suffering from routine or complex fracture injuries, which is exactly why we have chosen to pursue this partnership with CelgenTek Innovations,” said Randy S. Sessler, vice president and general manager of Zimmer Biomet’s global trauma business.
More articles on devices:
K2M’s 2015 revenue up 15% to $216M, but $39.4M net loss: 10 key notes
FDA clears Stryker’s Tritanium PL posterior lumbar cage: 6 key notes
3 new products for Breg at AAOS meeting: FastForm, Genesis Mid-Calf Walking Boot, Dynamic bracing
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
